Advertise on podcast: Personal Genomics Zone

Description

Why does 81% of genomic research exclude most of humanity? Dr. Manuel Corpas examines how genomic diversity—or its absence—shapes the future of precision medicine. Exploring health equity metrics (HEIM), pharmacogenomics, and the global infrastructure needed to make genomic medicine work for everyone, not just a few. Featuring insights on building inclusive genomic research across Latin America, the Middle East, and beyond.

Unlock Personal Genomics Zone podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from Personal Genomics Zone podcast

Why LLMs Can Hurt Your Academic Writing If You Trust Them Too Much

2026/01/25

I spend many hours working with LLMs to help me support my academic writing. This post summarises what I have learned. If you are using LLMs to help write academic papers, grant applications, or technical reports, these observations might save you from some painful mistakes. You can listen to the extended version for this blog […]

Missing Pieces: Why Genomic Diversity Is the Key to Better Science

2025/12/10

Presented at the UK–Indonesia Health Genomics Forum, London, 25 November 2025 When we speak about the future of precision medicine, it is easy to focus on the technology. We talk about sequencing platforms, AI systems, analytical pipelines and discovery engines. Yet the real foundation of precision medicine is something much more fundamental. Precision medicine cannot […]

The Precision Medicine Paradox: Why Partial Data Cannot Deliver Global Health

2025/12/01

By Dr Manuel Corpas Precision medicine is built on a contradiction. The field promises individualised care calibrated to each person’s biology, yet its foundations rest on data representing a fraction of humanity. After two decades at the intersection of genomics, artificial intelligence, and global health, I have reached a conclusion that the field must confront […]

Health Data Equity in Latin America in the Age of AI and Genomics

2025/10/07

A recap of my presentation to Britcham Brazil, 7 October 2025 This morning I had the privilege of presenting to a distinguished audience at the British Chamber of Commerce and Industry in Brazil (Britcham), as part of a webinar titled “Health Data Equity in Latin America in the Age of AI and Genomics.” I was […]

Biobanking Meets AI

2025/09/25

These weeks I will be putting here the lectures I am currently delivering for Biobanking for Data Science, a module that I lead at the University of Westminster for the MSc AI Digital Health course I also lead. I will be providing a summary and the recordings for these lectures. The research presented here is […]

My Journey to Advancing Health Equity in Genomics

2025/08/13

When I’m asked how I became a scientist, I usually smile, because the truth is, I’ve been aspiring to be one for over 30 years. My career didn’t follow the straight path I once imagined. I failed to get into medical school, so I turned to biomedical sciences instead. During my undergraduate studies, something unexpected […]

Why Diversity Must Be at the Heart of Precision Medicine

2025/07/13

by Dr. Manuel Corpas Despite breathtaking advances in genomics over the past two decades, we are failing to answer a fundamental question: who benefits from this progress? The sobering truth is that the benefits of precision medicine are overwhelmingly skewed toward people of European ancestry. In 2016, 81% of all genome-wide association studies (GWAS) were […]

Bridging Genomics’ Greatest Challenge: The Diversity Gap

2025/06/24

Genomics holds the promise to revolutionize healthcare—offering tailored diagnoses, treatments, and prevention strategies. But as I shared in my recent talk, this vision remains dangerously incomplete without one critical ingredient: diversity. At the heart of my presentation, delivered on 26 June 2025, was a stark reminder from Popejoy and Fullerton’s landmark 2016 Nature paper: over […]

🔬 Fireside Chat with Professor Yves Moreau: AI, Genomics & the Ethics of Technology

2025/05/10

In this episode of Personal Genomics Zone, I sit down with Professor Yves Moreau from KU Leuven for a deep and thought-provoking conversation on the intersections of artificial intelligence, genomics, and society. Our connection goes back to our shared contributions to the DECIPHER database — a foundational project in rare disease research that has shaped […]

A ChatGPT Moment for Genomics: Why Diversity Can’t Wait

2025/05/08

Imagine two people walk into a hospital. Same symptoms. Same diagnosis. One receives a treatment that works like magic. The other? Nothing. Why? Because what’s written in our DNA is as unique as our fingerprint. And the hard truth is: the science that informs healthcare—its research, data, and trials—has been built on just a handful […]